Australia markets close in 1 hour 44 minutes
  • ALL ORDS

    6,848.60
    +76.60 (+1.13%)
     
  • ASX 200

    6,638.10
    +76.50 (+1.17%)
     
  • AUD/USD

    0.7314
    +0.0027 (+0.37%)
     
  • OIL

    43.46
    +0.40 (+0.93%)
     
  • GOLD

    1,820.50
    -17.30 (-0.94%)
     
  • BTC-AUD

    25,076.13
    +45.02 (+0.18%)
     
  • CMC Crypto 200

    367.48
    +6.05 (+1.67%)
     
  • AUD/EUR

    0.6172
    +0.0020 (+0.32%)
     
  • AUD/NZD

    1.0481
    -0.0045 (-0.43%)
     
  • NZX 50

    12,564.73
    +62.99 (+0.50%)
     
  • NASDAQ

    11,905.94
    -0.50 (-0.00%)
     
  • FTSE

    6,333.84
    -17.61 (-0.28%)
     
  • Dow Jones

    29,591.27
    +327.79 (+1.12%)
     
  • DAX

    13,126.97
    -10.28 (-0.08%)
     
  • Hang Seng

    26,487.84
    +1.64 (+0.01%)
     
  • NIKKEI 225

    26,196.64
    +669.27 (+2.62%)
     

Acerus to Report Third Quarter 2020 Financial Results and Host Investor Call

·1-min read

Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its third quarter 2020 financial and operating results on Tuesday, November 3, 2020 before the market opens. The company will host a conference call on Tuesday, November 3, 2020 at 10:00 a.m. Eastern Time.

To access the call live, please dial 416-406-0743 or 1-800-898-3989 and use access code 5998289#. Listeners are encouraged to dial in 10 minutes before the call begins to avoid delays. A replay of the conference call will be available until 11:59 p.m. Eastern Time on Tuesday, November 10, 2020 by dialing 905-694-9451 or 1-800-408-3053, using access code: 4330175#.

About Acerus

Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company focused on the commercialization and development of innovative prescription products that improve patient experience, with a primary focus in the field of men’s health. The Company commercializes its products via its own salesforce in the United States and Canada, and through a global network of licensed distributors in other territories.

Acerus’ shares trade on TSX under the symbol ASP and on OTCQB under the symbol ASPCF. For more information, visit www.aceruspharma.com and follow us on Twitter and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201027005097/en/

Contacts

Company Contact
ir@aceruspharma.com

Investor Relations Contact
Chris Witty
Acerus Investor Relations
(646) 438-9385
cwitty@darrowir.com